Drug Trial Radar · NCT04410991
Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2)
Last checked: Nov 20, 2026Latest source record: Jul 2, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
899
Actual
Start
Jun 11, 2020
Primary completion
Jul 16, 2024
Study completion Jul 16, 2024
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- Jun 1, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: To assess efficacy of daily SAR442168 compared to a daily dose of 14 mg teriflunomide (Aubagio) measured by annualized adjudicated relapse rate (ARR) in participants with relapsing forms of MS Secondary Objective: To assess efficacy of SAR442168 compared to teriflunomide (Aubagio) on disability progression, MRI lesions, cognitive performance and quality of life To evaluate the safety and tolerability of daily SAR442168 To evaluate pharmacodynamics (PD) of SAR442168
Conditions
- Relapsing Multiple Sclerosis
Interventions
TolebrutinibDrug
Pharmaceutical form: Tablet Route of administration: Oral
Teriflunomide HMR1726Drug
Pharmaceutical form: Tablet Route of administration: Oral
Placebo to match TolebrutinibDrug
Pharmaceutical form: Tablet Route of administration: Oral
Placebo to match TeriflunomideDrug
Pharmaceutical form: Tablet Route of administration: Oral
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized Relapse Rate (ARR) as Assessed by Confirmed Protocol-defined Adjudicated RelapsesTime frame: Baseline (Day 1) to approximately 48 months
Locations
186 sites in 28 countries. Site status is shown where the registry gives one.
North Central Neurology Associates, PC-Site Number:8400009
Cullman, Alabama
Center for Neurology and Spine-Site Number:8400089
Phoenix, Arizona
Arcadia Neurology Center-Site Number:8400070
Arcadia, California
Multiple Sclerosis Center of California-Site Number:8400135
Newport Beach, California
Harbor UCLA-Site Number:8400088
Torrance, California
Mountain Neurological Research Center, Inc.-Site Number:8400128
Basalt, Colorado
Advanced Neurosciences Research-Site Number:8400025
Fort Collins, Colorado
South Florida Neurology Associates-Site Number:8400029
Boca Raton, Florida
University of Florida Health-Site Number:8400159
Gainesville, Florida
Neurology Associates, PA-Site Number:8400004
Maitland, Florida
University of Miami-Site Number:8400063
Miami, Florida
Infinity Clinical Research-Site Number:8400008
Sunrise, Florida
University of South Florida-Site Number:8400006
Tampa, Florida
Meridian Clinical Research-Site Number:8400003
Savannah, Georgia
Consultants In Neurology-Site Number:8400011
Northbrook, Illinois
Prairie Education and Research Cooperative-Site Number:8400071
Springfield, Illinois
Fort Wayne Neurological Center-Site Number:8400039
Fort Wayne, Indiana
CHI Saint Joseph Medical Group Neurology-Site Number:8400110
Lexington, Kentucky
University of Kentucky-Site Number:8400106
Lexington, Kentucky
Norton Neurology MS Services-Site Number:8400127
Louisville, Kentucky
The NeuroMedical Center-Site Number:8400057
Baton Rouge, Louisiana
International Neurorehabilitation Institute-Site Number:8400034
Lutherville-Timonium, Maryland
Wayne State University-Site Number:8400046
Detroit, Michigan
Minneapolis Clinic of Neurology-Site Number:8400051
Minneapolis, Minnesota
Saint Luke's Hospital-Site Number:8400153
Kansas City, Missouri
West Omaha Family Physicians-Site Number:8400139
Omaha, Nebraska
University Of Nebraska-Site Number:8400129
Omaha, Nebraska
Hackensack University Hospital-Site Number:8400047
Hackensack, New Jersey
University of New Mexico-Site Number:8400032
Albuquerque, New Mexico
South Shore Neurologic Associates-Site Number:8400100
Patchogue, New York
Novant Health Multiple Sclerosis Care Center - South Park-Site Number:8400120
Charlotte, North Carolina
Meridian Clinical Research, LLC-Site Number:8400005
Raleigh, North Carolina
Sanford Brain & Spine Center-Site Number:8400126
Fargo, North Dakota
Dayton Center for Neurological Disorders-Site Number:8400081
Centerville, Ohio
Jefferson Neurology Associates-Site Number:8400016
Philadelphia, Pennsylvania
Premier Neurology-Site Number:8400069
Greer, South Carolina
Advanced Neuroscience Center-Site Number:8400035
Franklin, Tennessee
Sibyl Wray, MD, Neurology, PC-Site Number:8400007
Knoxville, Tennessee
Mt Olympus Medical Research-Site Number:8400163
Katy, Texas
Neurology Center of San Antonio-Site Number:8400036
San Antonio, Texas
Showing 40 of 186 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.